A B S T R A C T
INTRODUCTION
Modest increases in the potassium concentration of plasma evoke vasodilation in several vascular beds of men and animals (1) (2) (3) (4) (5) (6) (7) . This effect is probably related to the critical role played by potassium ion in the excitation processes of vascular smooth mnuscle cells (8) . The magniitude of this K+-induced vasodilation may be attenuated in hypertensive animals (9, 10) ; we have reported previously our evidence suggesting that limb vasodilator responses to K+ in renal hypertensive dogs (9) and rats (10) are less than those in normotensive control animals. These abnormal responses in renal hypertensive animals suggest to us that there may be an underlying defect in the K+ metabolism of vascular smooth muscle cells.
We were most interested in determining whether such abnormalities were also present in hypertensive men. Therefore, in the present study we measured limb vascular responses in normotensive and essential hypertensive men to acute increnments in K+ concentrationis in limiib plasma. Our findings indicate that a significant l)roportion of essential hypertensive men may also have ness. At time of study the normotensive subjects were convalescing, afebrile, and not receiving vasoactive drugs, including digitalis preparations. 20 patients had essential hypertension of mild to moderate severity documented by thorough study which included hospital diastolic blood pressures averaging above 90 mm Hg during hospital days 4-6, normal rapid sequence intravenous pyelograms, normal 24 h urine vanilmandelic acid excretion, and normal serum sodium, potassium, and calcium concentrations. Renal angiography was performed on one patient (C. L. V.) and interpreted as indicating no abnormalities. Severity indices in hypertensives were calculated according to the criteria of the Veterans Administration Cooperative Study (11) . No hypertensives had retinal hemorrhages, exudates, or papilledema. All antihypertensive or vasoactive drugs and diets were discontir;ued at least 4 wk before the response study (except in the case of W. E. D., whose guanethidine and hydrochlorothiazide were continued until 1 wk and 48 h, respectively, before study). Two hypertensives were receiving maintenance doses of digitoxin, but these and the other subjects had no clinically discernible cardiac insufficiency. No subjects had elevated serum creatinine or blood urea nitrogen concentrations, or significant proteinuria.
All subjects participating were fully informed by the authors of the purposes, procedures, and hazards of the experiment; written consent was obtained.
These volunteers were studied in the resting, postabsorptive state, and supine position with laboratory temperature ranging from 26 to 270C. The procedures employed for infusions and measurement of limb intravascular pressures and calculation of blood flows by indicator-dilution have been described in detail (12, 13) . Briefly, we used a jet injection system to infuse solutions intrabrachial arterially at 8.2 ml/min and at 37°C. All solutions contained indicator, approximately 0.06 AtCi "mI/ml ("8'I-labeled human serum albumin in isotonic sodium chloride solution, Albumotope, E. R. Squibb & Sons, Princeton, N. J., or IHSA I 131, Mallinckrodt Chemical Works, St. Louis, Mo.). In 25 subjects an additional indicator was added to all solutions: approximately 0.05 mg indocyanine green dye/ml (Cardio-Green, contributed by Hynson, Westcott & Dunning, Inc., Baltimore, Md.). The experimental solutions also contained isosmolar (285 mosmol/liter) KCl. Control and experimental solutions were brought to volume with isosmolar NaCl solution. Infused at 8.2 ml/min, the solutions containing KCl delivered 0.077, 0.154, or 0.307 meq K+/min to brachial arterial blood. The solutions containing KCl were always administered in order of increasing dose. The effect of each infusion of KCl was compared with "resting" hemodynamics measured during a preceding paired infusion of control solution.
During infusions, dye concentrations in ipsilateral limb venous blood were monitored in 15 normotensive and 10 hypertensive subjects by withdrawing venous blood at 2.2 ml/min through a cuvette-densitometer system (model DTL, Gilson Medical Electronics, Inc., Middleton, Wis.), as previously described (13) . When a reasonably steady-state venous dye concentration was detected (8-13 min after beginning the infusion), we sampled ipsilateral cephalic and basilic venous and contralateral brachial arterial blood simultaneously. In the remaining subjects we sampled blood at the 10th and 15th min of each infusion. We calculated blood flow from the isotope concentrations of these samples. In 15 normotensive and 10 hypertensive subjects we also measured hematocrit, serum sodium and potassium concentrations, and osmolality of these samples as previously described (14) . Serum calcium and magnesium concentrations were measured on a Perkin-Elmer Atomic Absorption Spectrometer (model 290, Perkin-Elmer Corp., Norwalk, Conn.). In addition we studied the effect of the conitrol and KCl infusions on limb blood hematocrit and plasma calcium and magnesium concentrations by comparing limb output concentrations directly measured in cephalic venous serum with calculated limb input concentrations. The calculating equation for input concentrations, which adjusted limb arterial concentrations for the dilutional effect of the 8.2 ml/min infusion, has been presented (13) .
During infusions, we recorded pressures in the ipsilateral cephalic and basilic veins and contralateral brachial artery. The calculating equations for limb blood flow and vascular resistance have been presented (13) . Flows and resistances were expresse(d on a per limb volume basis. All experiments reported were considered technically satisfactory by our defined criteria (13) .
Additional laboratory studies were performed on 12 hypertensive subjects. These studies included 24-h creatinine clearances in duplicate, 24 h urine Na+ and K+ excretion, and measurement of plasma renin activity both after 8 h recumbency and after 4 h ambulation. In all but two subjects antihypertensive therapy had been discontinued 2-4 wk before this additional testing (one subject (C. L. V.) was receiving a combination of hydrochlorothiazide, hydralazine, methyldopa, and guanethidine; one subject (W. L. E.) was receiving hydrochlorothiazide). No subject was on a sodium-restricted diet. Plasma renin activity was measured by radioimmunoassay using procedures described by Haber, Koerner, Page, Kliman, and Purode (14) .
For data analysis we used the paired Student t test (15) to compare responses to control isosmolar NaCl solution with those to the paired isosmolar KCl solution, to compare responses in hypertensives with those in normotensives, to compare serum electrolyte concentrations during saline and KCl infusions, and to compare the additional measurements made in the two groups of hypertensive patients. In hypertensives and in normotensives linear correlation and regression coefficients were calculated for each dose level of KCl to determine if there were significant relationships between limb initial resistance (IR: resistance during the paired control isosmolar NaCl infusion), and magnitude of response to KCl (AR).' Homogeneity of regression coefficients was tested. Analysis of covariance was then used to compare regression-adjusted responses in hypertensives with those in normotensives.
RESULTS
Clinical data on the subjects are presented in Table I Table III . Neither control nor experimental infusions had significant effects on systemic arterial or venous pressures in either group of subjects (P > 0.1). Over the course of the experiments, limb resistance measured during the control infusions did not significantly change in either group (P > 0.2). In contrast, infusion of 0.154 or 0.307 meq K+/min decreased limb vasctular resistance and increased limb blood flow in both hypertensive and normotensive subjects (P < 0.001). In hypertensives, increases in limb blood flow and decreases in vascular resistance were not significantly different from those values in normotensives (P > 0.05). Indocyanine green dye concentrations in ipsilateral venous blood during infusions indicated that a steady-state blood flow was usually achieved during both NaCl and KCl infusions; that the response to the KCl infusion did not tend to wane with time; that there was a steady return to, but not below, base-line flow levels during the following control infusion; and that there were no apparent qualitative differences in responses in hypertensives and normotensives. Responses in subjects in whom indocyanine green dye was used were not dissimilar from those in whom it was not used.
During KCI infusion, we often noted flushing of skin of the ipsilateral forearm and hand, and most subjects noted mild and not uncomfortable sensations in that hand, but not elsewhere in the body. They described these sensations as "warmth," "burning," "tingling," "numbness" and/or "pressure." Sensations were apparently similar in normotensives and hypertensives.
"Base-line" limb vascular resistances (during control infusions of isosmolar NaCl solution) were significantly greater (P < 0.05) in hypertensives than in normotensives. Because there is evidence that the magnitude of vascular response (-AR) to K+ is a function of the 1.7 (8) 139.3±1.6 (17) [Ca++], meq/liter 3.7+0.1 (22) 3.9i0.1 (8) 3.7+0.1 (18) [Mg++], meq/liter 1.8240.02 (22) 1.8540.12 (8) 1.85±0.06 (18) Hct, ml/100 ml 42.1+0.5 (74) 42.840.9 (24) 42.8+0.8 (25) 43.241.1 (25) Means±SEM; number of observations indicated in parentheses. Because there were significant correlations between IR and AR and because IR was significantly greater in hypertensives than in normotensives, we also compared responses in hypertensives and normotensives by using analysis of covariance, which adjusted responses for their regression on initial resistance. The means of these adjusted AR ±SEM are also presented in Table III. Analysis of covariance corroborated the impression from Fig. lc that responses in hypertensives to 0.307 meq K+/min were significantly less than those in normotensives (P = 0.02). If responses from the six hypertensives falling above the 95% confidence intervals were omitted, however, analysis of covariance would no longer indicate significant differences between normotensives and hypertensives at this dose level (P > 0.05). In addition there were no significant differences in responses at the two lesser dose levels of KCl. We used covariance analysis-adjusted means plus SEM from Table III to construct log dose-response curves for normotensives and hypertensives and found them to be linear.
The hypertensive group was older than the normotensive group. Therefore we repeated analysis of covariance omitting responses in the five youngest normotensive subjects so there was no longer a significant difference in ages. Results of this analysis were similar to the results using data from the entire group; responses IR (mm Hg/mI /min/100 cm3 o io 20 intervals (Fig. 1c) (14) . Five of the six (83%) low responders and 71% of normal responders were considered to have hypertension of moderate severity. Finally, there were no significant differences between calculated limb input and measured output (cephalic venous) hematocrits, indicating that the infusions formed a simple volume additive to brachial arterial blood, as has been reported by others in the case of saline infusions (16) . In contrast, measured output concentrations of calcium and magnesium significantly exceeded (P < 0.05) calculated input concentrations during the control NaCl infusions. This finding confirms our previous report (13) and suggests that during the saline infusions calcium and magnesium ions move along concentration gradients from the extravascular into the intravascular space. Interestingly, we detected no similar shifts during infusion of KCl. We detected no differences between such ion shifts in hypertensives and normotensives. in hypertensives to 0.307 meq K+/min remained significantly lower (P = 0.04) than those in normotensives. We performed additional studies on 12 hypertensive subjects, attempting to asses the status of renal function and plasma renin activities (PRA). Five of these were among the subjects with markedly attenuated responses to 0.307 meq K+/min ("low" responders). Seven subjects had responses falling within the 95% confidence DISCUSSION The results of the present studies indicate that in man intrabrachial arterial infusions of KCI, producing modest increments in limb plasma potassium concentrations, decrease limb vascular resistance in a dose-related manner. The KCI infusions do not change limb concentrations of calcium or magnesium; hence, the decrease in limb resistance is probably not an effect of induced changes in these other vasoactive ions. Previous studies indicate that the response is to the potassium rather than to the chloride ion (3) .
We attribute the observed reduction in limb resistance to vasodilation because the KCI infusions did not alter limb blood hematocrit and because there is evidence that blood viscosity is not decreased by K+ (17) .
Potassium-evoked dilation in the limb vascular bed of man has been previously reported (4, 5) and is similar to that which has been observed by many investigators in vivo and in vitro in vessels of other species (1-3, 6, 7, 18) . In man the vasodilation is not attributable to release of histamine, acetylcholine, or to betaadrenergic stimulation (4) . limb, rather than a response to systemic effects of the ion (3, 19) . It is likely that the response we observed is, at least in part, independent of local neural structures (20) , because in the dog the response is not blocked by phentolamine or nerve section (3) . Furthermore, the response is observed in vitro and is not blocked by tetrodotoxin (18) .
There is electrophysiological evidence that the vasoactivity evoked by K+ involves direct action on membrane phenomena in the vascular smooth muscle cells (21) Recalling the blocking effects of ouabain, potassiuminduced vasodilation is attenuated in the limbs of renal hypertensive dogs (9) and rats (10) . This K4 abnormality in hypertensives is apparently specific, because we have found no evidence for altered responses to a number of other vasoactive cations and agents (9, 24) . These observations have naturally led us to speculate that there may be an underlying defect in Na+-K+-ATPase enzyme systems in vascular smooth muscle in renal hypertensives (9) . Such a defect could decrease the activity of the cellular electrogenic pump, tending to depolarize cell membranes, either generally, or in specific "pacemaker" cells (25) . Membrane depolarization might account for the impaired vascular relaxation and decreased stimulatory thresholds (26) in hypertension. Inhibition of the electrogenic pu1mp might also help explain some abnormalities which have been observed in vascular wall composition in hypertensives (27) .
Our present data indicate that, like renal hypertensive animals a significant proportion of essential hypertensive nmen also appear to have attenuatedl vasodilator responses to K+. We reached this conclusion by interpreting our data in terms of the highly significant positive relationship in both normotensives and hvpertensives between magnitude of response to K+ (AR) and the level of IR. Considering this relationship, one would expect that hvpertensives, with higher limb resistances than normotensives, would have greater vasodilator responses to K+, as they (1o to other vasodilator agents (9, 12 (Fig. 1) , one-third of the hypertensive subjects actually appear to have markedly attenuated responses to the highest dose level of K+. Our conclusion is further supported by covariance analysis which indicates that responses in the hypertensive men as a group are significantly lower than those in the nornmotensive meni. It is noteworthy that we analyzed our data from renal hypertensive animals in a similar manner and arrived at similar conclusions (9, 10) .
In using covariance analysis we have assumed that regression coefficients in the two groups were homogeneous; our data lead us to conclude that this assumption was valid. We have additional evidence that suggests that the regression of vasodilator responses on IR is independent of the source of variation in resistance (28) : In the forelimbs of dogs we measured vascular responses to intrabrachial arterial infusions of methacholine while producing stepwise increases in limb initial vascular resistance by several maneuvers: hemorrhage, local nerve stimulation, and local infusion of angiotensin II. In these dogs we found that the regression of limb response on IR was homogeneous for all methods used to alter resistance.
Our finding of attenuated responses to K+ in essential hypertensive men cannot be attributed to differences between the hypertensive and normotensive groups in age, body weight, limb volume, limb resting blood flows, blood hematocrit levels or serum concentrations of potassium, sodium, calcium, or magnesium. With one exception, the hypertensive subjects had not received therapy for 1 mo before study, so it is unlikely that differences in responses can be attributed to the effects of antihypertensive drugs. Two of the hypertensive subjects, however, were receiving digitoxin at the time of the study. Mean serum K+ concentrations in the two groups were identical, and there were no significant differences in creatinine clearance, and urine Na+ and K+ excretions. Furthermore, symptoms of renal disease such as nocturia were no more prevalent in the low responders. Thus we failed to find real evidence to suggest that the low responders had any more renal dysfunction than did the other hypertensives. These results argue against the possibility that the attenuated responses in the hypertensive group as a whole are attributable to occult renal hypertension (32) . Nevertheless, we do not feel that we have excluded this possibility, which requires further study.
The very fact that we identified a group of low responders and a group of normal responders within our hypertensives suggests heterogeneity of disease mechanisms. It is noteworthy that, if data from the six low responders are excluded from our statistical analyses, we are no longer able to demonstrate any significant difference between responses to K+ in normotensives and hypertensives. Thus it is entirely possible that only certain essential hypertensives have these attenuated responses to K+.
In another study we found no evidence for attenuation of vascular responses to K' in genetically hypertensive rats of the New Zealand strain (10) . Genetically hypertensive rats have been considered to be the closest animal model of essential hypertension in man (33) , but our findings may indicate basic differences in disease mechanisms. On the other hand, disease' mechanisms in the genetically hypertensive rats may be similar to those in the essential hypertensive men we categorized as normal responders. The normal responses in genetically hypertensive rats, however, make it umlikely that the attenuated responses to K+ we have observed in rats, dogs, and men can be attributed to the effects of the elevated intravascular pressures. Rather, it appears to us that these abnormalities may reflect causative disease processes.
Our present observations allow us to extend our hypothesis of a defect in cellular Na+-K+ATPase enzyme systems underlying hypertension to include a proportion of men with essential hypertension. In this regard abnormalities in vascular muscle cell electrolyte metabolism may constitute a "common denominator" in several forms of hypertension, as we suggested several years ago (34) . In renal hypertension such abnormalities might conceivably be the effects of decreased excretion and therefore abnormally elevated body levels of substances which inhibit Na+-K+-activated ATPase, such as methylguanidine (35, 36) , which, interestingly, is known to evoke vasoconstriction (37) and to elevate blood pressure (38) . In essential hypertensive men such enzyme (or pump) abnormalities might be attributable to genetic-induced defects. If so, identification of such defects could lead to the development of specific therapy. In this regard it is interesting that Limas and Cohn (39) have recently reported that several antihypertensive agents, including hydralazine and diazoxide, appear to evoke vasodilation by stimulating Na+-K+-ATPase of vascular smooth muscle.
